Natural product-derived Life-extension therapy: Isoliquiritigenin, isolated from Licorice (Glycyrrhiza glabra), inhibits the expression of Ribosomal protein S6 kinase 1 (p70S6 Kinase) and extends mammalian life span, 28/December/2016, 10. 48 pm

Molecular therapy for Myocardial Infarction: Methazolamide, a carbonic anhydrase inhibitor used in the treatment of glaucoma, inhibits DNA damage responses, increases telomerase expression, inhibits telomere shortening, and promotes cardiomyocyte survival after myocardial infarction via up-regulation of PNUTS, 28/December/2016, 6.43 pm
December 28, 2016
Therapeutic insights into “awakening the sleeping/cancer-protecting angels” in mutant p53-expressing human tumors: Physcion 8-O-β-glucopyranoside, a major ingredient isolated from Radix et Rhizoma Rhei and and Rhubarb, increases the expression of tumor suppressor p53 homologue TA-p73/p63, PTEN, TPM1, TIMP3, BTG2, PDCD4, SPRY1/2 and CCM1/KRIT1 and induces regression of p53-mutated human tumors via down regulation of its target gene, 29/December/2016, 11.04 pm
December 29, 2016
Show all

What they say?

A recent study from the Institute of Healthy Ageing, Centre for Diabetes and Endocrinology, Department of Medicine, University College London, London WC1E 6JJ, UK shows that “Ribosomal protein S6 kinase 1 signaling regulates mammalian life span.” This study was published in the 2 October 2009 issue of the Journal “Science” (I.F: 31.477 ) by Prof Dominic J. Withers, Dr. Selman C and others.


What we say

On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMDreports, for the first time, that: Natural product-derived Life-extension therapy: Isoliquiritigenin, isolated from Licorice (Glycyrrhiza glabra), inhibits the expression of Ribosomal protein S6 kinase 1 (p70S6 Kinase) and extends mammalian life span


Research findings to Therapeutic opportunity: 

isoliquiritigenin-suppresses-p70s6-kinase-to-promote-longevity

Figure 1. Isoliquiritigenin functions as a longevity promoter by decreasing the expression of p70 s6 kInase

This study suggests an miRNA-based life extension therapy. Isoliquiritigenin, by  decreasing  the expression of its target gene, it may suppress Ribosomal protein S6 kinase 1 (p70S6 Kinase) expression. Thereby, it may promote: (1) resistance to bone, immune, and motor dysfunction; (2) insulin sensitivity; and (3) longevity (figs. 1 and 2).   

price-100[easy_payment currency=”USD”]

Thus, pharmacological formulations encompassing “Isoliquiritigenin or its analogues or Isoliquiritigenin in combination with any of the known longevity-promoting compound(s) can be used to extend the lifespan of an individual (fig. 2).


Details of the research findings: 

Idea Proposed/Formulated (with experimental evidence) by:

Dr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

Undisclosed Information: How Isoliquiritigenin decreases the expression of p70 S6 Kinase and promotes mammalian life span?

# Research cooperation

Amount: $100 #


References:

CitationBoominathan, L.,  Natural product-derived Life-extension therapy: Isoliquiritigenin, isolated from Licorice (Glycyrrhiza glabra), inhibits the expression of Ribosomal protein S6 kinase 1 (p70S6 Kinase) and extends mammalian life span, 28/December/2016, 10. 48 pm, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Web: http://genomediscovery.org or newbioideas.com

Courtesy: When you cite drop us a line at info@genomediscovery.org

Comments are closed.